ADVERTISEMENTs

Benjamin Lalani named first Samvid Scholar from Johns Hopkins

Lalani founded the Pump Avenue Foundation, a nonprofit focused on redistributing insulin pumps and glucose monitors to underinsured patients.

Benjamin Lalani / Johns Hopkins University

Benjamin Lalani, a 2023 graduate of Johns Hopkins University, has been named a 2025 Samvid Scholar, making him the first university alum to receive the prestigious award. The announcement was made by Johns Hopkins University, which confirmed the honor in a recent report.

The Samvid Scholars program, launched in 2021, supports mission-driven students pursuing graduate degrees in fields such as medicine, public policy, and STEM. Each scholar receives $100,000 toward their studies. Johns Hopkins said the program receives around 1,000 applications annually, with only 20 students selected.

Lalani graduated with a degree in molecular and cellular biology and is currently pursuing an MD at Harvard Medical School. According to Johns Hopkins, he has long-standing interests in medicine, technology, and global health.

Before entering college, Lalani founded the Pump Avenue Foundation, a nonprofit focused on redistributing insulin pumps and glucose monitors to underinsured patients. Johns Hopkins reported that the foundation now serves over 130 patients across seven U.S. states and internationally in Tanzania, Somalia, and India.

“Through Pump Avenue, Ben has aided in the implementation of insulin pump programs in four rural and urban hospitals internationally, leading staff training, patient onboarding, and equipment delivery,” the university said.

Lalani has also contributed to research on digital health and clinical decision support. “He has co-authored over 20 peer-reviewed publications and abstracts and has given presentations at national conferences hosted by the American Diabetes Association, Diabetes Technology Society, American Association of Clinical Endocrinology, and Endocrine Society,” Johns Hopkins said.

His work includes evaluating a dynamic insulin dosing calculator for hospitalized patients and comparing artificial intelligence and human coaching in diabetes prevention during a phase 3 clinical trial.

Lalani has experience in the private sector as well. “He has also worked in strategy consulting at ClearView Healthcare Partners, advising Fortune 500 and early-stage life sciences companies on product development, pricing, and launch strategies,” Johns Hopkins noted.

Looking ahead, Lalani intends to focus on academic–industry collaborations. Johns Hopkins said he aims to lead “the development, evaluation, and global delivery of medical technologies” as a physician–innovator.

The Samvid Scholars program is funded by Samvid Ventures, a philanthropic foundation that supports education and entrepreneurship.

 

 

Comments

Related